Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity-Reference-Cited by-同舟云学术

Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity

Published:2015-05 Issue:5 Volume:122 Page:1008-1015
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Hwang Christopher K.,Hubbard G. Baker,Hutchinson Amy K.,Lambert Scott R.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference41 articles.

1. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity;Alon;Nat Med,1995

2. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo;Kim;Nature,1993

3. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization;Pierce;Proc Natl Acad Sci U S A,1995

4. Mechanisms and management of retinopathy of prematurity;Hartnett;N Engl J Med,2012

5. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome;White;J Pediatr Ophthalmol Strabismus,1997

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-Year Clinical Outcomes of Intravitreal Bevacizumab Versus Laser Photocoagulation for ROP;Journal of Pediatric Ophthalmology & Strabismus;2024-01

2. Prevalence and pattern of retinopathy of prematurity at two national referral hospitals in Uganda: a cross-sectional study;BMC Ophthalmology;2023-11-22

3. Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity;Journal of Pediatric Ophthalmology & Strabismus;2023-11

4. The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis;Italian Journal of Pediatrics;2023-10-09

5. Advances in development of exosomes for ophthalmic therapeutics;Advanced Drug Delivery Reviews;2023-08